Pacira Pharmaceuticals, Inc. (PCRX)
-NasdaqGS 29.08 
0.24(0.83%) 4:00PM EDT|After Hours
:
29.08 0.00 (0.00%) 4:31PM EDT
| Prev Close: | 28.84 |
|---|
| Open: | 28.95 |
|---|
| Bid: | 25.88 x 200 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 34.20 |
|---|
| Beta: | 1.46 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 28.41 - 30.01 |
|---|
| 52wk Range: | 9.90 - 30.94 |
|---|
| Volume: | 311,466 |
|---|
| Avg Vol (3m): | 500,153 |
|---|
| Market Cap: | 961.01M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -1.98 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- PCRX Trading Below Director's Recent Buy Priceat Forbes(Mon, May 20)
- PACIRA PHARMACEUTICALS, INC. FinancialsEDGAR Online Financials(Wed, May 15)
- SALT 2013: The 5 Best Ideas of the Year Aheadat TheStreet(Fri, May 10)
- Pacira Reports Wider LossZacks(Fri, May 10)
- Pacira Pharmaceuticals Inc. Stock Downgraded (PCRX)at TheStreet(Fri, May 10)
- Pacira Pharmaceuticals Increases Sales but Misses Estimates on Earningsat Motley Fool(Wed, May 8)
- Pacira Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, May 8)
- Pacira Pharmaceuticals, Inc. Earnings Call scheduled for 9:00 am ET todayCCBN(Wed, May 8)
- Q1 2013 Pacira Pharmaceuticals, Inc. Earnings Release - Before Market OpenCCBN(Wed, May 8)
- Pacira Pharmaceuticals, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care ConferenceBusiness Wire(Wed, May 8)
- Pacira Pharmaceuticals, Inc. Reports $10.4 Million in First Quarter EXPAREL Revenue and Full First Quarter 2013 Financial ResultsBusiness Wire(Wed, May 8)
- PACIRA PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online(Wed, May 8)
- Bearish Options Active On Gold Miners ETFat Seeking Alpha(Tue, May 7)
- Two New Studies Support Use of EXPAREL via Infiltration Into the Transversus Abdominis Plane for Postsurgical Pain ControlBusiness Wire(Mon, May 6)
- Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2013 Financial Results Webcast and Conference CallBusiness Wire(Wed, May 1)
Key Statistics
| Forward P/E (1 yr): | 74.56 |
|---|
| P/S (ttm): | 22.23 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -1.70 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.43 |
|---|
| Mean Recommendation*: | 1.4 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, commercializes, and manufactures pharmaceutical products for use in hospitals and ambulatory surgery centers worldwide.
View More